Henry Schein falls after missing quarterly profit estimates

Henry Schein (HSIC.O) reported Q2 adjusted EPS of $1.10, missing analyst estimates of $1.19, primarily driven by softer U.S. dental product demand attributed to high interest rates and inflation, causing its shares to fall nearly 5% premarket. Despite slightly exceeding revenue estimates, the company, which has faced declining revenue and investor pressure to diversify (including a 12% stake by KKR), maintained its 2025 financial guidance, signaling ongoing challenges in its core market.

Analysis

Henry Schein (HSIC) reported a mixed second quarter, characterized by a significant earnings miss but a marginal revenue beat, triggering a nearly 5% premarket share price decline. The company posted an adjusted EPS of $1.10, falling short of the $1.19 consensus estimate, which management attributed to softer U.S. demand for non-urgent dental products due to high interest rates and inflation. While this domestic softness was concentrated in May before normalizing, it was partially offset by strong growth in international markets, allowing quarterly revenue to reach $3.24 billion, slightly above the $3.22 billion estimate. The results arrive amidst a backdrop of two years of declining revenue and activist pressure, highlighted by KKR's 12% stake acquired in January. Despite the quarterly profit miss, management reaffirmed its full-year 2025 guidance, including an adjusted EPS range of $4.80 to $4.94 and sales growth of 2% to 4%, positioning 2025 as a foundational year for a return to high-single to low-double-digit earnings growth.

Key Decisions for Investors

• Investors should monitor U.S. macroeconomic data closely, as continued consumer sensitivity to inflation and interest rates presents a primary risk to the company's reaffirmed 2025 guidance.
• The divergence between a weak U.S. market and strong international sales warrants scrutiny; continued outperformance abroad is critical to offsetting domestic pressures and meeting annual targets.
• Given that management frames 2025 as a transitional 'base year' and KKR is an active shareholder, long-term investors may watch for strategic initiatives on diversification before committing new capital.